Cells used in in vitro cell culture, especially animal cell culture, get attached to the surface of the container. These cells need to be detached for further use. Detachment of adherent cells from the surface or substrate to which these are attached is done with the help of cell dissociation reagents. Cell dissociation reagents along with chelators are largely used during cell passaging. The cell dissociation reagents carry out collagenolytic and proteolytic activity for the disengagement of cell lines and tissues from the plastic or glass surfaces to increase the isolation efficiency with high cell viability.
Despite the worldwide use of enzymes for cell dissociation applications over the years, their mechanisms of action in cell isolation and detachment are little known. Selection of the suitable enzyme of choice is based upon the type of tissue or cells in culture. The global cell dissociation reagents market is driven by superior technological advancements in the area of non-enzymatic cell dissociation along with chelators with reduced neutralization steps, lower enzyme denaturation or autodegradation, and quality control to confirm homogeneity and reliability to provide maximum yield of functionally viable cells during cell passaging from culture vessels. Issues with sterility maintenance, unsuitable for use in in vivo diagnostics, and occurrences of high decontamination with bacteria if kept still for longer time in the laboratory leading to shorter expiry periods for usage restrain the growth of the market.
The global cell dissociation reagents market has been segmented based on product type, product morphology, application, and end-user. In terms of product type, the global cell dissociation reagents market has been classified into enzymatic cell dissociation reagents and non-enzymatic cell dissociation reagents. The enzymatic cell dissociation reagents is further categorized into trypsin collagenase, elastase, protease, and others. Based on product morphology, the market has been bifurcated into solutions and powders. In terms of application, the global cell dissociation reagents market has been segmented into antibody production, veterinary applications, cell culture maintenance, immunoassays (radiolabelling assays), and others. The cell culture maintenance segment is expected to account for the largest share of the global cell dissociation reagents market during the forecast period. Based on end-user, the global cell dissociation reagents market is divided into research/academic institutes, diagnostic labs, pharmaceutical companies, cell banks, and others. The research/academic institutes segment is anticipated to expand at a high growth rate during the forecast period.
The recombinant cell dissociation reagents that have non-mammalian, non-bacterial origin which will not harm the structural and functional quality of cell membrane and cell surface epitopes and proteins by keeping them intact. This acts as a major driver of the global cell dissociation reagents market. An emerging trend in the market is to provide cost-effective cell dissociation reagents prepared by intense quality analysis for sterility, performance, low antibody titer, mycoplasmas and endotoxins along with intricate manufacturing process that retain the enzymatic activity for longer periods.
In terms of region, the global cell dissociation reagents market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is estimated to show a continual growth driven by increasing biotech start-ups due to economical manufacturing of cell dissociation reagents, rising demand for cost effective and low cost cell dissociation reagents, and increasing cell maintenance banks and specialty research institutes. North America is projected to dominate the global cell dissociation reagents market due to high adoption of new and technologically advanced products with cutting edge technologies, increasing research and development investments, and rising demand from research institutes.
Key players in the global cell dissociation reagents market are Sigma-Aldrich Co. LLC., GE Healthcare, Thermo Fisher Scientific Inc., HiMedia Laboratories, Atlanta Biologicals, Inc., EuroClone S.p.A., Irvine Scientific, Gemini Bio-Products, STEMCELL Technologies, Inc., Cyagen Biosciences, Inc., and PromoCell GmbH, among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.